Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease

By Wannamethee S.   Lowe G.   Shaper A.   Rumley A.   Lennon L.   Whincup P.  

Diabetologia, Vol. 47, Iss. 9, 2004-09 ,pp. : 1557-1565

Springer Publishing Company

Access to resources Recommend Favorite

Plasma levels and potential roles of catestatin in patients with coronary heart disease

By Liu Lin   Ding Wenhui   Zhao Feng   Shi Libin   Pang Yongzheng   Tang Chaoshu  

Scandinavian Cardiovascular Journal, Vol. 47, Iss. 4, 2013-08 ,pp. : 217-224

Informa Healthcare

Access to resources Recommend Favorite

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

By Title L.M.   Giddens K.   McInerney M.M.   McQueen M.J.   Nassar B.A.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1747-1753

Elsevier

Access to resources Recommend Favorite

Usefulness of attenuated heart rate recovery immediately after exercise to predict endothelial dysfunction in patients with suspected coronary artery disease

By Huang P.-H.   Leu H.-B.   Chen J.-W.   Cheng C.-M.   Huang C.-Y.   Tuan T.-C.   Ding P.Y.-A.   Lin S.-J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 10-13

Elsevier

Access to resources Recommend Favorite